By Dr. (Prof.) Tarun Kumar, Senior Director – Medanta Moolchand Heart Centre, Cardiology
High blood pressure (hypertension) is called the “silent killer” because it often has no symptoms until complications arise. Many patients visiting a private hospital in Delhi don’t realize they have hypertension until it damages their heart, brain, or kidneys. At Moolchand, one of the top hospitals in Delhi, our superb physicians deliver outcomes that matter—using cutting-edge diagnostics, compassionate care, and integrity-driven treatment plans at affordable prices.
· Damages Arteries: Causes narrowing, stiffness, and increases risk of atherosclerosis.
· Increases Risk of Heart Attack: Promotes plaque buildup in coronary arteries.
· Leads to Heart Failure: Continuous strain weakens the heart muscle.
· Raises Stroke Risk: Affects blood flow to the brain, leading to ischemic or hemorrhagic stroke.
The latest international guidelines have updated how doctors should diagnose, evaluate, and treat hypertension. Key highlights:
Section
2017 Recommendation
2025 Recommendation
Terminology
Hypertensive urgency
Now referred to as Severe Hypertension
Secondary Hypertension
Not routine
Screening for primary aldosteronism is recommended in adults with resistant hypertension (even without low potassium).
Primary Aldosteronism Screening
Limited
Continue most BP medications (except MRA) before screening to avoid delays.
Lifestyle Approaches
General salt reduction
Potassium-based salt substitutes can be useful—except in CKD or when potassium retention is an issue.
BP Treatment Thresholds
Start meds if SBP ≥130/DBP ≥80 with 10-yr CVD risk ≥10%
Lower threshold: Start meds at ≥130/80 if risk ≥7.5% (PREVENT model) or in diabetes/CKD—even without clinical CVD.
Diabetes
ACEi/ARB may be considered if albuminuria present
ACEi/ARB are recommended if eGFR <60 or albuminuria ≥30 mg/g.
Chronic Kidney Disease
ACEi reasonable, ARB if ACEi not tolerated
RAAS inhibitor (ACEi or ARB) strongly recommended in CKD with albuminuria ≥30 mg/g.
Stroke (Acute ICH/Ischemic)
Lower BP cautiously >220 mmHg
Immediate but smooth BP control to 130–140 mmHg after ICH; avoid aggressive lowering post-reperfusion in ischemic stroke.
Cognitive Health
BP lowering “reasonable” to prevent decline
Target SBP <130 mmHg recommended to prevent dementia/MCI.
Pregnancy
Avoid ACEi/renin inhibitors
BP control <140/90 mmHg for chronic hypertension; SBP ≥160/DBP ≥110 must be treated within 30–60 min; low-dose aspirin advised to prevent preeclampsia.
Resistant Hypertension
Few recommendations
Detailed evaluation + multidisciplinary approach; renal denervation (RDN) considered in select patients.
Severe Hypertension (Non-emergency)
Acute IV drugs sometimes used
Not recommended in patients without organ damage; careful stepwise outpatient management preferred.
1. Lifestyle Modifications:
· Eat a diet rich in fruits, vegetables, and whole grains.
· Use potassium-based salt substitutes where safe.
· Exercise at least 150 minutes a week.
· Maintain a healthy weight.
· Quit smoking and reduce alcohol.
2. Medication Management:
· ACE inhibitors, ARBs, calcium channel blockers, or diuretics depending on patient profile.
· Tailored therapy for diabetes, CKD, or pregnancy as per new guidelines.
· Monitoring by superb physicians at a trusted Delhi hospital ensures safety.
3. Regular Monitoring:
· Home BP monitoring for early detection of spikes.
· Periodic visits to specialists for dose adjustment.
Hypertension is no longer managed with a “one size fits all” approach—the 2025 recommendations emphasize personalized care, early screening for secondary causes, lifestyle interventions like potassium salt, and tighter thresholds for high-risk groups.
At Moolchand, among the best hospitals in India, patients trust us for compassionate care, integrity-driven treatment, cutting-edge technology, superb physicians, and affordable prices. Managing blood pressure early not only protects the heart but also prevents kidney disease, stroke, and dementia.
By Dr. (Prof.) Tarun Kumar, Senior Director – Medanta Moolchand Heart Centre, Cardiology